Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lung Cancer in Hungary.
Bogos K, Kiss Z, Gálffy G, Tamási L, Ostoros G, Müller V, Urbán L, Bittner N, Sárosi V, Vastag A, Polányi Z, Nagy-Erdei Z, Vokó Z, Nagy B, Horváth K, Rokszin G, Abonyi-Tóth Z, Barcza Z, Moldvay J. Bogos K, et al. Among authors: moldvay j. J Thorac Oncol. 2020 May;15(5):692-699. doi: 10.1016/j.jtho.2019.11.001. J Thorac Oncol. 2020. PMID: 32340676 Free article. No abstract available.
[Incidence, risk factors and prevention of cisplatin-induced nephrotoxicity in patients with lung cancer].
Losonczy G, Máthé C, Müller V, Szondy K, Moldvay J. Losonczy G, et al. Among authors: moldvay j. Magy Onkol. 2010 Dec;54(4):289-96. doi: 10.1556/MOnkol.54.2010.4.3. Magy Onkol. 2010. PMID: 21163759 Free article. Hungarian.
Moreover, decreased renal function will not limit the full dose administration of several other cytotoxic agents. Losonczy G, Mathe C, Muller V, Szondy K, Moldvay J. Incidence, risk factors and prevention of cisplatin-induced nephrotoxicity in patients with lung can …
Moreover, decreased renal function will not limit the full dose administration of several other cytotoxic agents. Losonczy G, Mathe C, Mulle …
[Analysis of drug therapy of lung cancer in Hungary].
Moldvay J, Rokszin G, Abonyi-Tóth Z, Katona L, Kovács G. Moldvay J, et al. Magy Onkol. 2013 Mar;57(1):33-8. Epub 2012 Dec 20. Magy Onkol. 2013. PMID: 23573520 Free article. Hungarian.
Subtype-specific KRAS mutations in advanced lung adenocarcinoma: a retrospective study of patients treated with platinum-based chemotherapy.
Cserepes M, Ostoros G, Lohinai Z, Raso E, Barbai T, Timar J, Rozsas A, Moldvay J, Kovalszky I, Fabian K, Gyulai M, Ghanim B, Laszlo V, Klikovits T, Hoda MA, Grusch M, Berger W, Klepetko W, Hegedus B, Dome B. Cserepes M, et al. Among authors: moldvay j. Eur J Cancer. 2014 Jul;50(10):1819-1828. doi: 10.1016/j.ejca.2014.04.001. Epub 2014 Apr 22. Eur J Cancer. 2014. PMID: 24768329 Free article.
Lung cancer drug therapy in Hungary - 3-year experience.
Moldvay J, Rokszin G, Abonyi-Tóth Z, Katona L, Fábián K, Kovács G. Moldvay J, et al. Onco Targets Ther. 2015 May 13;8:1031-8. doi: 10.2147/OTT.S65794. eCollection 2015. Onco Targets Ther. 2015. PMID: 25999737 Free PMC article.
103 results